🌟 Alumni Alert: Deana Mohr-Haralampieva & MUVON Therapeutics AG A quick summary as to why we need #personalized #regenerativetherapies for stress incontinence: 👉 Addressing a prevalent issue: With 25% of women experiencing stress incontinence post-childbirth and up to 40% of women over 40 affected, the team focuses on regenerative muscle cell therapy, providing a promising alternative to existing synthetic material-based treatments. 👉 Innovative treatment approach: Through a Phase 2 study, patients are receiving transplants of their body's own muscle precursor cells, offering potential long-term relief and significantly improving quality of life. Learn more and participate in the clinical study: www.muvon-studie.ch MUVON Therapeutics AG Therapeutics, a spin-off from the University of Zurich, aims to establish personalized regenerative therapies as the standard of care, offering hope to millions suffering from debilitating diseases. Let's spread awareness and empower those affected by stress incontinence! #RegenerativeTherapies #StressIncontinence #MUVONTherapeutics #UZHspinoff #BEIalumni
🌟 Thrilled to share this insightful read on stress incontinence in our latest #ScienceCommunications article! Shedding light on this prevalent issue and discussing potential solutions. Let's break down barriers and promote understanding in healthcare together. Check it out! (German translation in the comments) #ScienceCommunication #patientrecruitment #Healthcare #StressUrinaryIncontinence #SciComm #Wysszurich 🚀📝 https://lnkd.in/dV95cTaE
